Opie's Cardiovascular Drugs: A Companion to Braunwald's Heart Disease
Opie's Cardiovascular Drugs: A Companion to Braunwald's Heart Disease
YOU SAVE £8.44
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
- More about Opie's Cardiovascular Drugs: A Companion to Braunwald's Heart Disease
Opie's Cardiovascular Drugs, 9th Edition, is the go-to reference for quick access to frequently used drugs in cardiology, with updated guidelines, evidence-based implications, and a consistent format for each drug class. It covers key topics such as ESC and NLA guidelines, lipid-lowering therapy, diabetes drugs, obesity drugs, inflammation, and antithrombotic therapies. The eBook version includes enhanced features for easy access on various devices.
Format: Paperback / softback
Length: 720 pages
Publication date: 03 December 2020
Publisher: Elsevier - Health Sciences Division
Opie's Cardiovascular Drugs, 9th Edition, is a comprehensive and authoritative reference for quick access to frequently used drugs in all phases of care for cardiac patients. As a part of the Braunwald family of renowned cardiology references, this compact title offers crucial information in an easily accessible format, ideal for cardiologists, residents, cardiology fellows, medical students, nurses, and other cardiac care providers.
Updated to include the latest guidelines and evidence-based implications, the book offers clear and concise explanations and pertinent clinical facts for all classes of cardiac drugs, as well as all the latest clinical trial results and evidence for the pharmacologic treatment of heart disease.
The book employs a new, consistent format for each drug class, including an overview and guidelines for use, mechanisms of action, differences among drugs in class, data for use, side effects, and drug interactions. It also covers key topics such as new ESC and NLA guidelines, advances in lipid-lowering therapy, new diabetes drugs that improve cardiovascular outcomes, obesity drugs and cardiovascular and metabolic effects, drugs targeting inflammation, and combinations of antithrombotic therapies with analysis of risk-benefit.
Furthermore, the book provides guidance on how to effectively manage comorbid diseases. It contains dozens of unique "Opiegram" diagrams that demystify complex mechanisms of action and other drug processes, many updated to reflect current pathologic understanding of mechanisms.
An enhanced eBook version is included with the purchase, allowing users to access all of the text, figures, and references from the book on a variety of devices.
Weight: 532g
Dimension: 113 x 189 x 28 (mm)
ISBN-13: 9780323673617
Edition number: 9 Revised edition
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.